2019
DOI: 10.1080/15569527.2018.1518330
|View full text |Cite
|
Sign up to set email alerts
|

The protective effects of astaxanthin against cisplatin-induced retinal toxicity

Abstract: This study investigated the toxic effects of an antineoplastic agent, Cisplatin (CIS), on retinal cells and the potential capacity of Astaxanthin (ASTA) to elicit a future therapeutic protocol in CIS-induced retinal toxicity. Six groups were formed for the assessment; control (healthy; Group 1), olive oil (olive oil only; Group 2), ASTA control group (ASTA only, Group 3), the single intraperitoneal (IP) dose of 16 mg/kg CIS (CIS only group; Group 4), 16 mg/kg CIS + 25 mg/kg (IP) ASTA (Group 5) and 16 mg/kg CIS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
9
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 42 publications
4
9
0
Order By: Relevance
“…When in combination with Cis, in MCF7, SKBR3, and MCF12A cell lines, Asta interfered with this drug action, as in the mixture, Cis 10 µM lost its effect. Asta has been previously described to confer protection against oxidative stress [121] and, in in vivo studies with rats, it had a protective effect against Cis-induced toxicity in the gastrointestinal tract [122], ear [123], and also retina [124], which could partially explain the loss of effect observed in the present study.…”
Section: Discussionsupporting
confidence: 57%
“…When in combination with Cis, in MCF7, SKBR3, and MCF12A cell lines, Asta interfered with this drug action, as in the mixture, Cis 10 µM lost its effect. Asta has been previously described to confer protection against oxidative stress [121] and, in in vivo studies with rats, it had a protective effect against Cis-induced toxicity in the gastrointestinal tract [122], ear [123], and also retina [124], which could partially explain the loss of effect observed in the present study.…”
Section: Discussionsupporting
confidence: 57%
“…Our model reflects the early stage of acute pancreatitis, and as expected, MDA levels and MPO activity were increased while GSH was decreased [5,10,[36][37][38][39]. GSH levels were later increased by ATX [36,40]. However, Q10 addition was not effective, parallel with the data of the abovementioned study [22].…”
Section: Discussionsupporting
confidence: 67%
“…In rat retinas, a single intraperitoneal injection with CIS (16 mg/kg) increased the levels of MDA, as well as decreased the levels of reduced glutathione (GSH). Immunohistochemical assays revealed an increase in labeling for 8-hydroxy-2p-deoxyguanosine (marker of DNA damage) in horizontal cells and for endothelial nitric oxide synthase (eNO) in retinal blood vessel cells [ 114 ]. Blood samples from rats administered for 14 days with CIS (2.5 mg/kg) also revealed an increase in MDA, myeloperoxidase (MPO), and the levels of the total oxidant system, but also in the pro-inflammatory cytokines, including the tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β).…”
Section: Drugs and Medicinementioning
confidence: 99%
“…After treatment with CIS, the retinal tissue showed degeneration, edema, and vascular congestion with disorganization of the retinal layers. Optic nerve tissue anomalies have also been observed, such as destruction, hemorrhage, edema, and an increase in the number of astrocytes and polymorphonuclear leukocytes [ 114 , 115 , 116 , 117 ]. These data indicate that the ocular disorders found in patients treated with CIS may be due to an imbalance of antioxidant defenses and the production of ROS and nitrogen species, which induces cell damage and an inflammatory process.…”
Section: Drugs and Medicinementioning
confidence: 99%